Plasminogen activator inhibitor-1 as a marker of cardiovascular response in professional mountain ultra-marathon runners

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Describing children’s changes using clinical chemistry analytes
4. Review
5. Assessment of vitamin D status – a changing landscape
6. Opinion Papers
7. Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
8. The principles of Health Technology Assessment in laboratory medicine
9. Genetics and Molecular Diagnostics
10. Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people
11. General Clinical Chemistry and Laboratory Medicine
12. Influence of pneumatic tube system transport on routinely assessed and spectrophotometric cerebrospinal fluid parameters
13. Estimation of hematocrit in filter paper dried bloodspots by potassium measurement: advantage of use of perimeter ring samples over circular center sub-punch samples
14. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves’ disease
15. Comparison of four immunoassays to measure serum ferritin concentrations and iron deficiency prevalence among non-pregnant Cambodian women and Congolese children
16. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis
17. Hematology and Coagulation
18. Neutrophil CD64 Index as a superior biomarker for early diagnosis of infection in febrile patients in the hematology department
19. Dilute Russell’s viper venom time reagents in lupus anticoagulant testing: a well-considered choice
20. Reference Values and Biological Variations
21. Pediatric reference intervals for alkaline phosphatase
22. Cancer Diagnostics
23. Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target
24. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
25. Cardiovascular Diseases
26. Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI
27. Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome
28. Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery
29. Diabetes
30. A simple colorimetric assay for measuring fructosamine 3 kinase activity
31. Acknowledgment
32. Acknowledgment
33. Letters to the Editor
34. Normalisation issues in glucose measurements using phlebotomy tubes with liquid additives
35. Utility of dilution tests in investigating interference in the free thyroxine assay
36. Plasminogen activator inhibitor-1 as a marker of cardiovascular response in professional mountain ultra-marathon runners
37. Pitfalls of LSD screening assays: comparison of KIMS and CEDIA immunoassays with LC-MS
38. A two site comparison of two point-of-care activated clotting time systems
39. Detection of the common South-East Asian β⁰-thalassemia mutations in samples with borderline HbA₂ levels
40. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains